【Media coverage】NIKKEI Biotechnology and Business

An article introducing our company was published.

NIKKEI Biotechnology and Business (October 30, 2024）

Venture Explorations「RadioNano Therapeutics, a developer of BNCT drugs, to conduct clinical development for solid tumors.」

https://bio.nikkeibp.co.jp/atcl/column/16/021500017/102800351/